The Applied Pharmaceutical Nanotechnology (APN) Symposium will be held October 24th, in Cambridge MA. The symposium will have plenary talks by Omid Farokhzad (Seer Biosciences), Samir Mitragotri (Harvard University), and Vladimir Torchilin (Northeastern University). NCL’s Marina Dobrovolskaia, Sr. Principal Scientist and Head of NCL’s Immunology Division, will also speak at this year’s event. Her talk will be on the “Achievements, Disappointments, and Lessons Learned from Immunotoxicity Studies of Nanotechnology-Formulated Complex Drugs.”
For more information on this year’s APN Symposium, please visit https://www.bostonsociety.org/APN/.